Prescient Therapeutics Limited (AU:PTX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Prescient Therapeutics Limited has announced the cessation of 3 million options due to unmet conditions as of September 30, 2024. The options, initially set to expire on December 8, 2025, were discontinued because the required conditions were not satisfied. This update may interest investors tracking the company’s capital structure and future prospects.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “You Want to Believe That You’re Not a Fool”: Tesla Stock (NASDAQ:TSLA) Slides as Customers Fight Back Against Self-Driving Promises
- AMD or Intel: Stifel Chooses the Better AI Chip Stock to Buy Ahead of Earnings
- “Move at a Glacial Pace”: Starbucks Stock (NASDAQ:SBUX) Slips With New Cross-Promotion Plan for The Devil Wears Prada 2